文献速递传染病防控与疫情报告卫生政策与健康促进

2014-2019年美国商业保险与医疗补助人群HIV检测趋势

HIV Testing Trends Among Persons with Commercial Insurance or Medicaid - United States, 2014-2019.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-06-25

分析IBM MarketScan商业保险与CMS医疗补助理赔数据,估算2014-2019年≥13岁人群HIV检测比例变化及2019年人口学特征。两类保险中男性和非孕女性检测率均上升,但2019年仅4.0%商业保险与5.5%医疗补助人群接受检测。非西班牙裔黑人和西班牙裔检测率较高,年检测率需至少提高三倍并持续数年才能实现EHE目标。

要点

  • 2019年仅4.0%商业保险和5.5%医疗补助≥13岁人群接受HIV检测
  • 男性和非孕女性检测率在2014-2019年间均上升
  • 非西班牙裔黑人和西班牙裔检测率高于非西班牙裔白人

核心结论

  • 2014-2019年商业保险和医疗补助≥13岁男性和非孕女性HIV检测率上升,但2019年总体检测比例仍低(商业保险4.0%,医疗补助5.5%)。
  • 基于数学模型,年检测率需至少提高三倍并持续数年才能实现EHE倡议2025年≥95%HIV感染者知晓感染的目标。
  • 需在临床场所实施干预提高常规和基于风险的HIV检测,以帮助减少黑人和西班牙裔与非西班牙裔白人之间的HIV诊断差异。

研究设计与样本

  • 研究分析IBM MarketScan商业保险理赔数据库和CMS医疗补助理赔数据库的加权数据,估算2014-2019年商业保险或医疗补助≥13岁人群接受HIV检测的比例,并描述2019年人口学特征。

主要发现

  • 2014-2019年商业保险和医疗补助中≥13岁男性和非孕女性HIV检测率均上升。
  • 2019年仅4.0%商业保险人群和5.5%医疗补助人群接受HIV检测。
  • 2019年非西班牙裔黑人或非裔美国人和西班牙裔或拉丁裔人群HIV检测率较高。

关键数值与推荐

  • CDC建议所有13-64岁性活跃人群一生中至少接受一次常规opt-out HIV检测,无论年龄,对报告HIV感染相关行为者进行基于风险的检测。
  • 基于数学模型研究,年检测率需至少提高三倍并持续数年才能实现EHE倡议2025年≥95%HIV感染者知晓感染的目标。

临床怎么用

  • 在临床场所实施支持增加检测的干预措施,提高常规和基于风险的HIV检测至更高水平。
  • 公共卫生部门应与卫生系统合作实施干预,以支持增加检测并减少HIV诊断差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

HIV testing is a critical component of effective HIV prevention and care. CDC recommends routine opt-out HIV testing in health care settings for all sexually active persons aged 13-64 years at least once in their lifetime and risk-based testing regardless of age for those who report behaviors associated with HIV acquisition (1). However, recent studies show low HIV testing rates in clinical settings; HIV testing rates at visits to physician offices did not increase during 2009-2016 (2). The objective of the current study is to estimate temporal trends in HIV testing among persons with commercial insurance or Medicaid from 2014 through 2019 and describe their demographic characteristics in 2019. Weighted data from the IBM MarketScan Commercial Claims and Encounters database* (commercial insurance) and from the Centers for Medicare & Medicaid Services (CMS) claims database† (Medicaid) were analyzed to estimate the proportions of persons with commercial insurance or Medicaid who received testing for HIV. Testing rates increased among male and nonpregnant female persons aged ≥13 years with either type of coverage. In 2019, only 4.0% of those with commercial insurance and 5.5% of those with Medicaid received testing for HIV. Testing rates were higher among non-Hispanic Black or African American (Black) persons and Hispanic or Latino (Hispanic) persons. Based on mathematical modeling studies, these annual testing rates would need to increase at least threefold and be sustained over several years (3,4) to achieve the Ending the HIV Epidemic (EHE) in the U.S. initiative goal of ≥95% of persons with HIV being aware of their infection by 2025.§ Interventions need to be implemented to increase routine and risk-based HIV testing in clinical settings to higher levels that can help reduce disparities in HIV diagnoses between Black and Hispanic persons compared with non-Hispanic White (White) persons (5). Increased HIV testing is essential to achieve the goals of the EHE initiative and reduce disparities in HIV diagnoses; public health should partner with health care systems to implement interventions that support increased testing.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Henny KD, Zhu W, Huang YA, et al. HIV Testing Trends Among Persons with Commercial Insurance or Medicaid - United States, 2014-2019. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34166332. doi:10.15585/mmwr.mm7025a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。